HIV Research

HIV Particles Susceptible to Bee Venom

Toxin from bee venom has been shown by a recent study to kill HIV when delivered by nanoparticles. The best part is that these nanoparticles allowed researchers to target the HIV and leave surrounding cells unscathed. What is the goal for researchers with this study? They want to create a gel for women that could potentially stop HIV from spreading from person to person via sexual relations.

In some countries, HIV is a common scourge. The idea is to use such a gel in a preventative capacity. Mellitin is the toxin found in bee venom that has researchers feeling hopeful. It can break through the defenses of HIV particles. Researchers have not only used mellitin in anti-viral research, but also in cancer research because of the potent ability of the toxin to destroy cells.

The way researchers were able to use nanoparticles to deliver the toxin only to the HIV particles is through the creation of protective bumpers on the surface of the nanoparticles. These bumpers are too close together to allow regular cells to come into contact with the toxin. The significantly smaller HIV cells fit right between the bumpers and are destroyed.

While most HIV drugs merely fight to keep the disease from replicating, this toxin can actually destroy the envelope that normally keeps HIV particles safe from all attacks. This envelope adapts to protect the virus from various substances, but the toxin can successfully destroy the coating because it attacks all membranes with double layers – thus hepatitis is another disease that could be attacked using this method (both B and C types).

Another suggested use for the gel besides the prevention of HIV could be in helping couples where only one partner has HIV to conceive naturally without risk to the healthy partner. The gel would only target HIV, not sperm.

The initial experiments were performed in a laboratory, but it would not be very expensive to create enough of the mellitin anti-virus compound to perform clinical trials should the idea reach that stage.

HIV’s Protein Disguise Unveiled

A recent study has revealed that HIV-1 hijacks 25 different proteins in the body in order to cover its replication and hide from the immune system. It is hoped that the results of this study will help in research for better treatment options and diagnostic tools.

When leaving an infected cell, HIV particles encase themselves in proteins to disguise themselves from the immune system. While it’s believed that some of these proteins are selected with a specific purpose, others may simply be random proteins that get caught up in the guise.

Drug companies would like to target HIV particles by using the specific proteins to find them – the problem is that the HIV particles utilize so many different specific proteins that it would be impossible to hunt them all individually. This research hopes to narrow down the number of targets by figuring out which proteins are most vital to the survival of HIV particles.

Researchers hope to examine proteins from the cells that HIV most likes to hide in, such as T-cells and macrophages, in order to discover the proper target proteins. While HIV uses hundreds of proteins to mask its spread, only 25 of these proteins are held in common by the two most frequently infected immune system cell types.

CD44 seems to be one of these key proteins – of the 25 examined it is the only protein that can bind other cells to itself. This allows the virus to latch onto inflamed areas within the body. Macrophages and T-cells (the cells that HIV is most likely to travel through) are both used by the immune system to deal with inflammation. Thus HIV uses the body’s own defense system to infiltrate deeper and spread more rapidly – immune cells carry HIV particles to inflamed areas, and proteins like CD44 disguise the virus and allow it to latch on to the inflamed cells.

Go to Top